Fairvalue-Calculator Fairvalue-Calculator
EN DE

MediWound Ltd (MDWD) Fair Value & Analysis

Healthcare · US · Market cap $183M

Price$14.07
Fair Value$15.28
Upside+8.6%
Quality81/100
Evidence: Low Range $11.46 – $19.10

Fair value as of: Jun 24, 2026

Analysis

MediWound Ltd (MDWD) currently trades at $14.07, while our model-based Fair Value estimate is $15.28 — implying the stock looks roughly 8.6% undervalued today. We read business quality at 81/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is MediWound Ltd (MDWD) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $15.28 versus a price of $14.07 — about +9% (undervalued). Model-based estimate, not financial advice.
What is the fair value of MDWD?
Our 21-model fair value for MediWound Ltd is $15.28 (as of Jun 24, 2026), built from audited fundamentals. The current price is $14.07.
What is the quality score of MDWD?
MediWound Ltd has a Quality Score of 81/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.